Bolt Biotherapeutics, Inc. Common Stock — Rendiconto Finanziario Trimestrale (NASDAQ:BOLT) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 9.43 M
Employee 23
Founded 2015
CEO N/A
Website www.boltbio.com
Headquarter Delaware, United States
FIGI BBG00N8MY5V9
Industry Technology

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

9.43 M Capitalizzazione di mercato

Rapporto prezzo/utili

-0.31

Rapporto prezzo/fatturato

1.33

Notizie

Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?

Il CEO di Bolt Biotherapeutics Quinn acquista azioni per 686 dollari

Nemec, SVP di Bolt Biotherapeutics, acquista azioni per 686 dollari

Bolt Biotherapeutics CEO Quinn buys shares worth $686

Nemec, Bolt Biotherapeutics SVP, acquired shares worth $686

Azioni Bolt Biotherapeutics: iniziata copertura con rating Buy da H.C. Wainwright

Bolt Biotherapeutics stock initiated with Buy rating at H.C. Wainwright

Fidus Investment, Rocket Companies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Mr. Cooper Gr (NASDAQ:COOP), Bolt Biotherapeutics (NASDAQ:BOLT)

Bolt Biotherapeutics ritarda i dati clinici e riduce la forza lavoro del 50%

Bolt Biotherapeutics delays clinical data, cuts workforce by half